W. Va. Supreme Court: No Brand Name Failure to Warn Liability for Generic Drugs

W. Va. Supreme Court:  No Brand Name Failure to Warn Liability for Generic Drugs

The West Virginia Supreme Court, answering a question certified by the U.S. Court of Appeals for the Fourth Circuit, held that "there is no cause of action in West Virginia for failure to warn and negligent misrepresentation against a brand-name drug manufacturer when the drug ingested was produced by a generic drug manufacturer."  [5/12/18]

 

Search